Literature DB >> 31644395

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2019        PMID： 31644395      PMCID： PMC6816363          DOI： 10.1080/21645515.2019.1666591

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  6 in total

1.  PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance.

Authors:  Vivek Verma; Rajeev K Shrimali; Shamim Ahmad; Winjie Dai; Hua Wang; Sumin Lu; Rahul Nandre; Pankaj Gaur; Jose Lopez; Moshe Sade-Feldman; Keren Yizhak; Stacey L Bjorgaard; Keith T Flaherty; Jennifer A Wargo; Genevieve M Boland; Ryan J Sullivan; Gad Getz; Scott A Hammond; Ming Tan; Jingjing Qi; Phillip Wong; Taha Merghoub; Jedd Wolchok; Nir Hacohen; John E Janik; Mikayel Mkrtichyan; Seema Gupta; Samir N Khleif
Journal:  Nat Immunol       Date:  2019-07-29       Impact factor: 25.606

2.  Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.

Authors:  Sonya Abraham; Helene B Juel; Peter Bang; Hannah M Cheeseman; Rebecca B Dohn; Tom Cole; Max P Kristiansen; Karen S Korsholm; David Lewis; Anja W Olsen; Leon R McFarlane; Suzanne Day; Sara Knudsen; Kjersti Moen; Morten Ruhwald; Ingrid Kromann; Peter Andersen; Robin J Shattock; Frank Follmann
Journal:  Lancet Infect Dis       Date:  2019-08-12       Impact factor: 25.071

3.  Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial.

Authors:  E Antonio Chiocca; John S Yu; Rimas V Lukas; Isaac H Solomon; Keith L Ligon; Hiroshi Nakashima; Daniel A Triggs; David A Reardon; Patrick Wen; Brittany M Stopa; Ajay Naik; Jeremy Rudnick; Jethro L Hu; Priya Kumthekar; Bakhtiar Yamini; Jill Y Buck; Nathan Demars; John A Barrett; Arnold B Gelb; John Zhou; Francois Lebel; Laurence J N Cooper
Journal:  Sci Transl Med       Date:  2019-08-14       Impact factor: 17.956

4.  Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy.

Authors:  Anna Galstyan; Janet L Markman; Ekaterina S Shatalova; Antonella Chiechi; Alan J Korman; Rameshwar Patil; Dmytro Klymyshyn; Warren G Tourtellotte; Liron L Israel; Oliver Braubach; Vladimir A Ljubimov; Leila A Mashouf; Arshia Ramesh; Zachary B Grodzinski; Manuel L Penichet; Keith L Black; Eggehard Holler; Tao Sun; Hui Ding; Alexander V Ljubimov; Julia Y Ljubimova
Journal:  Nat Commun       Date:  2019-08-28       Impact factor: 14.919

5.  A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae.

Authors:  Mario F Feldman; Anne E Mayer Bridwell; Nichollas E Scott; Evgeny Vinogradov; Samuel R McKee; Sthefany M Chavez; Joy Twentyman; Christina L Stallings; David A Rosen; Christian M Harding
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-27       Impact factor: 11.205

6.  Antitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint Blockade.

Authors:  Netonia Marshall; Keino Hutchinson; Thomas U Marron; Mark Aleynick; Linda Hammerich; Ranjan Upadhyay; Judit Svensson-Arvelund; Brian D Brown; Miriam Merad; Joshua D Brody
Journal:  Cancer Discov       Date:  2019-08-02       Impact factor: 39.397
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.